BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 3894536)

  • 1. Serum squamous cell carcinoma antigen levels in women with neoplasms of the lower genital tract and in healthy controls.
    Neunteufel W; Tatra G; Bieglmayer C
    Arch Gynecol Obstet; 1989; 246(4):243-50. PubMed ID: 2619339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
    Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical studies on a new antigens associated with squamous cell cancer in oncogenesis of uterine cervical cancer].
    Uchimura M; Kenjo T; Kuroshima Y; Fujii A; Yamauchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jan; 43(1):73-9. PubMed ID: 1997617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
    Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the special tumor marker of cervical cancer of the uterus.
    Kato H
    Semin Surg Oncol; 1987; 3(1):55-63. PubMed ID: 3544141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers in gynecologic oncology.
    Montag TW
    Obstet Gynecol Surv; 1990 Feb; 45(2):94-105. PubMed ID: 2405313
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
    Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antigenicity and immunology of human cervical squamous cell carcinoma: a review.
    McCoy JP; Haines HG
    Am J Obstet Gynecol; 1981 Jun; 140(3):329-36. PubMed ID: 7018244
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.